Amgen Gets Failure-To-Warn Claims Axed From Enbrel Suit
A Florida federal judge has trimmed failure-to-warn claims from a woman's suit against Amgen and two other pharmaceutical companies alleging she suffered infections from taking the arthritis drug Enbrel, saying her...To view the full article, register now.
Already a subscriber? Click here to view full article